Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Shitara

Showing results (91-100 of 344) with videos related to

Pageof 35
Sort By:
Japanese Journal of Clinical Oncology|August 28, 2016
Phase 1 study of ombrabulin in combination with cisplatin (CDDP) in Japanese patients with advanced solid tumorsShunji Takahashi, Kenji Nakano, Tomoya Yokota, et al.
Japanese Journal of Clinical Oncology|February 22, 2011
Lapatinib plus trastuzumab for a patient with heavily pre-treated gastric cancer that progressed after trastuzumabKohei Shitara, Ayako Mizota, Yasushi Yatabe, et al.
Journal of Cancer Research and Clinical Oncology|May 22, 2023
Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS)Kohei Shitara, Ben George, Julien Taieb, et al.
Journal for Immunotherapy of Cancer|August 27, 2021
Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signalSho Isoyama, Shigeyuki Mori, Daisuke Sugiyama, et al.
BMC Palliative Care|August 5, 2015
Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort studyChihiro Kondoh, Kohei Shitara, Motoo Nomura, et al.
International Journal of Clinical Oncology|October 18, 2019
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trialKohei Shitara, Hiroki Hara, Takaki Yoshikawa, et al.
Japanese Journal of Clinical Oncology|September 30, 2008
Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1Kohei Shitara, Kei Muro, Takashi Ura, et al.
International Journal of Clinical Oncology|May 4, 2012
A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancerKohei Shitara, Akira Sawaki, Keitaro Matsuo, et al.
Journal of Cancer Research and Clinical Oncology|December 20, 2012
Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapyKohei Shitara, Satoshi Yuki, Kentaro Yamazaki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 25, 2012
Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasisKohei Shitara, Ayako Mizota, Keitaro Matsuo, et al.
Pageof 35

Showing results (91-100 of 344) with videos related to

Sort By:
Pageof 35
Japanese Journal of Clinical Oncology|August 28, 2016
Phase 1 study of ombrabulin in combination with cisplatin (CDDP) in Japanese patients with advanced solid tumorsShunji Takahashi, Kenji Nakano, Tomoya Yokota, et al.
Japanese Journal of Clinical Oncology|February 22, 2011
Lapatinib plus trastuzumab for a patient with heavily pre-treated gastric cancer that progressed after trastuzumabKohei Shitara, Ayako Mizota, Yasushi Yatabe, et al.
Journal of Cancer Research and Clinical Oncology|May 22, 2023
Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS)Kohei Shitara, Ben George, Julien Taieb, et al.
Journal for Immunotherapy of Cancer|August 27, 2021
Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signalSho Isoyama, Shigeyuki Mori, Daisuke Sugiyama, et al.
BMC Palliative Care|August 5, 2015
Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort studyChihiro Kondoh, Kohei Shitara, Motoo Nomura, et al.
International Journal of Clinical Oncology|October 18, 2019
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trialKohei Shitara, Hiroki Hara, Takaki Yoshikawa, et al.
Japanese Journal of Clinical Oncology|September 30, 2008
Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1Kohei Shitara, Kei Muro, Takashi Ura, et al.
International Journal of Clinical Oncology|May 4, 2012
A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancerKohei Shitara, Akira Sawaki, Keitaro Matsuo, et al.
Journal of Cancer Research and Clinical Oncology|December 20, 2012
Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapyKohei Shitara, Satoshi Yuki, Kentaro Yamazaki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 25, 2012
Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasisKohei Shitara, Ayako Mizota, Keitaro Matsuo, et al.
Pageof 35